WORKSHOP PROGRAM

Workshops are designed to share innovative experiences and practices, and to provide learning opportunities for our participants. They are half or full-day events that include interactive activities and focus on developing participants’ skills. 

Workshops can be booked through the regular Registration process. For delegates only interested in Workshops and not the actual Annual Meeting, please select 'Workshop Only' attendance in the registration process. 

WS01 - Identifying Patient Subgroups to Facilitate Personalized Policy Decision Making: Hands-On Exercises in Diabetes 

Date & Time: Saturday, June 15 | 9.00AM to 5.00PM 
Presenters: Dr. Junfeng Wang, Xinyu Li1, Haoyue Wang 
Summary: In this 6-hour workshop, the presenters will showcase how to identify patients subgroups based on their characteristics and risks, with unsupervised and supervised machine learning techniques. A recent pharmacoeconomic analysis in comparing different strategies of identifying diabetes subgroups and their health economics value will serve as a case study. Participants will gain hands-on experiences in data analysis (with R) 

 

WS02 - Hospital Based-HTA: From Innovation To Implementation 

Date & Time: Saturday, June 15 | 9.00AM to 5.00PM 
Presenters: Dr. Rossella Di Bidino 
Summary: HB-HTA is an heterogeneous phenomena in continuous evolution. The challenges it faces are context specific and differ in relation to HB-HTA stage of maturity. Furthermore, relationships with internal and external stakeholders are key to define the perceived value of HB-HTA. Real life experiences are shared to open a constructive and open discussion.  

 

WS03 - Characterizing why Rare Diseases Create Evidence Generation Challenges for HTA 

Date & Time: Saturday, June 15 | 9.00AM to 5.00PM 
Presenters: Dr Karen Facey, Sheela Upadhyaya, Dr Alicia Granados, Ms Lea Wiedmann, Ms Cara Philpott 
Summary: Rare diseases involve small patient numbers and often involve complex, chronic, life limiting conditions where clinical knowledge is evolving. This leads to uncertainties in evidence generation that need to be accounted for in HTA. This workshop will present project work from the new HTAi Rare Disease Interest Group exploring the impact of rare disease challenges on evidence generation and HTA. 

 

WS04 - How To Use The PriTec Tool For Network Prioritization Processes in Health Technology Assessment? 

Date & Time: Saturday, June 15 | 9.00AM to 5.00PM 
Presenters: Mrs Maria-Jose Faraldo-Valles, PhD Leonor Varela-Lema, Ms Noemí Raña-Villar, Ms Jutta Knabe Guerra 
Summary: PriTec is an automatically executable multi-criteria web application which enables networked prioritization of health technologies for assessment, monitoring or disinvestment, so that many users can jointly rank technologies. The workshop will approach the rationale behind the functioning and a joint prioritization exercise will be carried out. Besides, its use in the Spanish National Health System will be presented for discussion. 

 

WS05 - HTA 101: Introduction To Health Technology Assessment 

Date & Time: Saturday, June 15 | 9.00AM to 12.30PM 
Presenters: PhD Clifford Goodman 
Summary: This popular workshop course has been updated and offered at all HTAi annual meetings. HTA 101 provides an understanding of essential HTA concepts, methods, and current international HTA issues and trends that will enable attendees from high-, middle-, and low-income countries to be more prepared to engage in the scientific program and other aspects of the Annual Meeting. 

 

WS06 - Less Classic Roles That Patients And Their Organizations Can Have In HTA and Decision-Making 

Date & Time: Saturday, June 15 | 9.00AM to 12.30PM 
Presenters: Mr François Houÿez, Prof Dr Uwe Siebert, Prof Mondher Toumi, Prof Dr Isabelle Huys, Ms Hilde de Keyser 
Summary: Beside the classical roles of patients in HTA (scientific advice, scoping, assessment, sometimes appraisal), this workshop will describe and analyze how patients can accurately horizon scan to detect and prioritize technologies of interest, engage with their developers, generate patient experience data and compare different treatment options, contribute to decisions on early access programs, price discussions and managed-entry agreements. 

 

WS07 - Using Alternative Metrics To Quantify The Societal Burden Of Disease For Health Technology Assessment Processes 

Date & Time: Saturday, June 15 | 9.00AM to 12.30PM 
Presenters: Professor Of Health Economics Zanfina Ademi 
Summary: Traditionally, disability-adjusted life years and quality-adjusted life years have been the primary methods for estimating the burden of disease. Novel health-metric measures capable of more broadly quantifying the societal burden of ill health are needed. The productivity-adjusted life years metric considers the population-level impact of disease on productivity and facilitates the evaluation of costs from the societal perspective. 


WS08 - Assessing The Impact Of HTA As A Cornerstone Of Sustainable Health Systems 

Date & Time: Saturday, June 15 | 9.00AM to 12.30PM 
Presenters: Dr Juan Antonio Blasco-Amaro, Dr. Sophie Werkö, Peter Dyrda, MIchal Stanak, Dr. Susan Myles 
Summary: Sustainable health technology assessment (HTA) begins with demonstrating the value and impact of HTA.  Join this interactive workshop facilitated by senior practitioners from agencies that are members of the International Network of Agencies for HTA (INAHTA) to learn about approaches to assessing impact of HTA along with discussion of the challenges and opportunities in this important policy area. 

 

WS09 - A Holistic Approach To Assessment of Artificial Intelligence 

Date & Time: Saturday, June 15 | 1.30PM to 5.00PM 
Presenters: Dr. Iben Fasterholdt, Associate Professor Valeria E. Rac, Professor Rossana Cecchi, Pre PhD student Nanna Bluhme, Professor Kristian Kidholm 
Summary: In the coming years, artificial intelligence will play an increasingly bigger role at hospitals worldwide. Hence, a multidisciplinary group of experts and patients developed Model for ASsessing the value of AI (MAS-AI) to support a robust introduction of AI technologies into healthcare. Researchers from Denmark, Canada, and Italy will present MAS-AI and participants will apply MAS-AI on the case studies. 

 

WS10 - Operationalizing Lifecycle Approaches in HTA 

Date & Time: Saturday, June 15 | 1.30PM to 5.00PM 
Presenters: Dr Ramiro Gilardino, Meindert Boysen, Dr. Nicole Mittmann, Nathalie Largeron, Sheela Upadhyaya, Franz Pitchler 
Summary: The workshop aims to address uncertainties and changes across the lifespan of a technology by providing guidance on developing LC-HTA processes and key considerations for implementation. Attendees, including HTA professionals, industry representatives, regulators, payers, clinicians, and patients, will participate in small group activities to apply the LC-HTA framework to a case study, identify steps, and discuss implementation issues and solutions. 

 

WS11 - Using Real-World Data for Health Technology Assessment: Modern Causal Inference and Machine Learning Methods and Their Challenges 

Date & Time: Saturday, June 15 | 1.30PM to 5.00PM 
Presenters: Dr Yingying Zhang, Prof. Dr. Andrea Manca, Dr. Noemi Kreif, Mr. Alastair Bennett, Miss Anusha Ihalapathirana 
Summary: The workshop introduces causal inference statistical models and machine learning as potential solutions to challenges of using real-world data in HTA. It covers two causal inference methods that deal with confounding, and compares statistical and machine learning models for predicting health outcomes, with examples from case studies. The practical session introduces R codes for applying some of the statistical methods. 

 

WS12 - An Introduction To Early Health Technology Assessment 

Date & Time: Saturday, June 15 | 1.30PM to 5.00PM 
Presenters: Dr. Janet Bouttell, Dr. Geert Frederix, Dr. Janneke Grutters, Dr. Linne Støme, Dr. Marcia Tummers
Summary: Early HTA provides a unique opportunity to facilitate multi-stakeholder engagement and co-create healthcare innovations that meet society’s needs. Early HTA aims at steering both the development of and evidence generation on innovative technologies. In this workshop we provide a practical and interactive introduction to state-of-the-art methods to assess (potential) value before clinical evidence is available.


WS13 - Assessment of Artificial Intelligence Health Technologies: Methodologies, Tools, Case Studies and Challenges 

Date & Time: Sunday, June 16 | 9.00AM to 5.00PM 
Presenters: Dr. Rossella Di Bidino 
Summary: The diffusion of AI-based health technologies (AI-HT) is positioned to transform the organization of health systems. Health Technologies Assessment (HTA)  is adapting its methodologies to emerging AI-HT and their intended and unintended health, economic, social, ethical and other impacts. The workshop aims to share experiences, identify current challenges and give visibility to the expertises involved in the HTA of AI-HT. 

 

WS14 - Advanced Workshop in Information Retrieval: Recent Advances in Processes, Knowledge Sharing and Impact Assessment 

Date & Time: Sunday, June 16 | 9.00AM to 5.00PM 
Presenters: Ms Ingrid Harboe, Ms. Amanda Hodgson, Dr Siw Waffenschmidt, Ms Beatriz Casal-Acción 
Summary: Join the HTAi Information Retrieval Group (IRG) for its advanced workshop at the HTAi Annual Meeting. Learn from engaging speakers and expert searchers as we explore innovations in search practices along with challenges and opportunities to collaborate globally to advance best practice. A special focus will be the perspective of information specialists and searchers in the HTA community in Spain. 

 

WS15 - Navigating the Living Health Technology Assessment Journey: From Conceptualization to Implementation 

Date & Time: Sunday, June 16 | 9.00AM to 5.00PM 
Presenters: María Ximena Rojas-Reyes 
Summary: The incorporation of the Living Evidence model into HTA development requires guidance, training, and the development of skills among groups accustomed to traditional HTA methods. The LE-IHD project group has developed a comprehensive strategy for building capacity for this purpose among HTA-developers. This workshop provides an opportunity to delve in-depth into the approach with practical examples and hands-on support tools. 

 

WS16 - Innovating HTA Methods: Findings And Implications Of The H2020 HTx-Project 

Date & Time: Sunday, June 16 | 9.00AM to 5.00PM 
Presenters: Prof. Dr. Wim Goettsch, Prof. Dr. Zoltan Kaló, Dr. François Houÿez, Dr. Jamie Elvidge, Prof. Dr. Andrea Manca, Dr. Junfeng Wang, Dr. Saskia Knies, Prof. Dr. Diana Delnoij, Lifang Liu  
Summary: The EU H2020 HTx project will deliver its final results in June 2024. The consortium consisted of academic partners and HTA agencies who worked on innovative HTA methods supporting patient-centred, societally oriented, real-time decision-making on access and reimbursement of health technologies. This workshop offers an interactive deep dive into the main findings and their implications for HTA policy and practice. 

 

WS17 - Gender Equity and Health Technology Assessment - Where Are We and Where Do We Want to Go? 

Date & Time: Sunday, June 16 | 9.00AM to 12.30PM 
Presenters: Dr. Dimitra Panteli, Prof Elena Petelos 
Summary: Gender is a significant determinant of health, and it intersects with HTA in multiple ways. Taking a gender-sensitive approach to HTA is necessary for ensuring relevant decisions are appropriately informed to advance gender equality. This workshop aims to update our understanding of the link between gender and HTA and serve as an information gathering, skills-building and community-building exercise. 

 

WS18 - Patient Involvement In Decision-Making Processes: A Route Toward Sustainability And Healthcare Transformation In Low- And Middle-Income Countries? 

Date & Time: Sunday, June 16 | 9.00AM to 12.30PM 
Presenters: Dr Anke Holtorf, Ms Sheena Jasley Samonte, Mr Chris Munoz, Dr. Lorena Mesa Melgarejo, Dr. Andrea Gimenez 
Summary: This multi-stakeholder workshop addresses the current motives, enablers, and barriers in LMICs to strengthen evidence-informed decision-making for achieving greater sustainability and inclusivity in health systems. The participants will co-create and design potential multi-stakeholder pathways for HTA processes that are feasible and effective in the context of LMICs. 

 

WS19 - Doing What’s Right: Integrating Ethics Analysis In HTA? 

Date & Time: Sunday, June 16 | 9.00AM to 12.30PM 
Presenters: Prof. Pietro Refolo, Dr Bart Bloemen, Mr. Kenneth Bond, Prof Dario Sacchini, Prof Lars Sandman 
Summary: The relevance of incorporating ethical analysis into HTA is increasingly acknowledged not only because many health technologies raise ethical, legal and social issues, but also because HTA is an evaluative process. This workshop offers an introduction to the role of ethics in HTA, as well as a lively discussion of challenging case studies. 

 

WS20 - Generating Health-Related Quality of Life Data in Rare Conditions: A Neuromuscular Case Study 

Date & Time: Sunday, June 16 | 9.00AM to 12.30PM 
Presenters: Dr Tom Gleeson, Dr Clara Mukuria, Dr Nicole Gusset, Mr Peter Rouse 
Summary: This multi-stakeholder interactive workshop explores emerging methodologies for assessing value in HTA, with a particular focus on rare diseases, using neuromuscular conditions as a case study. The session aims to equip the audience with conceptual and practical skills to consider alternative methods of HRQoL data elicitation using patient perspectives, in conditions where conventional measures may not be fully appropriate. 

 

WS21 - Unlocking Rare Diseases Economic Modelling: Health Technology Assessment Implications, Methodological Standpoints, and Multi-Perspective Solutions for Current Challenges 

Date & Time: Sunday, June 16 | 1.30PM to 5.00PM 
Presenters: Andrew Briggs, Ms Ailsa Brown, Mr Christophe Sauboin, Mr Abhirup Dutta Majumdar, Dr. Rossella Di Bidino 
Summary: Economic modeling in rare diseases (RD) is uniquely complex, often requiring highly specialized inputs for clinical, epidemiological, and healthcare resource utilization. Further, heightened regulation and rapid therapeutic advancements add to the challenges faced by modelers. The RD interest group at Health Technology Assessment International (HTAi) has been tasked to identify these challenges and propose solutions, which we aim to present. 

 

WS22 - Patient And Citizen Involvement In Health Technology Assessment: Networks For Sustainability And Innovation 

Date & Time: Sunday, June 16 | 1.30PM to 5.00PM 
Presenters: Mrs. Catherine Koola, Dr Robyn Manuel, Dr Susannah Morris, Mr. Christopher Muñoz, Mr Zal Press 
Summary: This workshop, led by the HTAi Patient and Citizen Involvement Interest Group (PCIG) begins with an introduction to key concepts, methods and approaches to patient involvement, including examples of tools adapted internationally for efficient and good practice. This is followed by the choice of three deep dive dialogues: reporting and evaluating; sustainable practice; and the patient community role in innovation. 

 

WS23 - The Design Of Health Technology Assessment Processes Using Evidence-Informed Deliberative Processes In Low And Middle Income Countries 

Date & Time: Sunday, June 16 | 1.30PM to 5.00PM 
Presenters: Dr Wija Oortwijn, Dr. Maryam Huda, Dr Lyazzat Kosherbayeva 
Summary: On their path towards universal health coverage, governments need to make choices in the design of HTA processes which may be challenging in countries that have limited experience with HTA. This workshop provides practical guidance on how to make these choices, informed by the theory of evidence-informed deliberative processes (EDPs), international best practices and practical examples from several middle-income countries. 

 

HTAi 2024 ANNUAL MEETING

© Copyright 2023 HTAi